Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search